Welcome to the latest issue of Drug Discovery Today, Editors Choice. I hope you have enjoyed the previous issues in this new format. I’d be grateful for any suggestions or feedback on this new style emailing. Feel free to contact me on firstname.lastname@example.org
29 November, 2010
With the global economy remaining stagnant, Big Pharma companies are keen to develop blockbuster drugs that have a high financial ceiling. Rodger McMillan, VP of R&D at Astra Zeneca has said that “big pharma is a cash-rich industry – it has to be,” namely because of the huge costs in developing new drugs
24 November, 2010
London Genetics Limited and Astrimmune have entered into a collaboration to plan a biomarker identification programme for Astrimmune's early-stage pancreatic cancer vaccine candidate.
12 November, 2010
Researchers have taken the first steps towards understanding why a rare skin cancer that is rapidly increasing in incidence in Europe and the USA is not recognized by the body’s immune system.
08 November, 2010
A group of more than 40 industry, government and academic experts from all over Europe has reported that minipigs have many advantages for drug and chemical safety testing and could improve drug safety for humans.
04 November, 2010
Twenty-two team members of Quantum Pharmaceutical took part in this year’s ‘Big Zip’ charity zip-wire jump last Saturday at Newcastle’s Tyne Bridge.
04 November, 2010
Researchers have initially identified the neural pathways that control peace of mind in the human brain, which could lead to the development of new therapies in the treatment of anxiety disorders and depression.
03 November, 2010
Researchers have shown that they might be able to monitor the aging process in the brain by using MRI to measure brain lactic acid levels.
02 November, 2010